US3875013A - Article for detecting the fertile period and method for using same - Google Patents

Article for detecting the fertile period and method for using same Download PDF

Info

Publication number
US3875013A
US3875013A US333029A US33302973A US3875013A US 3875013 A US3875013 A US 3875013A US 333029 A US333029 A US 333029A US 33302973 A US33302973 A US 33302973A US 3875013 A US3875013 A US 3875013A
Authority
US
United States
Prior art keywords
female
acetyl
color
beta
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US333029A
Inventor
Jorge Martinez Manautou
Adolfo Rosado Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Priority to US333029A priority Critical patent/US3875013A/en
Priority to US05/562,743 priority patent/US3968011A/en
Application granted granted Critical
Publication of US3875013A publication Critical patent/US3875013A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
    • C12Q2334/10O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases p-Nitrophenol derivatives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/806Fertility tests

Definitions

  • the article is comprised of a porous support impregnated with at least one color developing compound such as p-nitrophenyl-n-acetyLB- d-glucosaminide and at least one buffer that develops a color when contacted with a female biological medium.
  • the development of the marked color is coincident with the fertile period, which indication of the fertile period can be used either for achieving fertilization or for preventing conception by the rhythmic method. Also, in the days preceding the expected menstrual period. the development of the marked color is coincident with the presence of pregnancy.
  • FIG.4 mq PRIOR ART 1 I I l I I I l l 1 l I -2'4 -22 -2o -
  • FIG.4
  • This invention relates to both a novel article useful for detecting the fcrtile period of the female. the pres ence of pregnancy and to a novel test method suitable for detecting the said fertile period or the presence of pregnancy.
  • the fertile period is usually a certain number of days before menstruation. That is. the period of fertility. or ovulation in the human female is sct from II to lo days before the next menstrual period and this calculation is used for the intended purpose.
  • calculations based on the onset of menscs are often inaccurate because the human female may o ⁇ ulatc at varying and unpredictable times.
  • the length of life of the ova and the spermatozoa which information is not truly known in vivo. must also be added to the calculated period which further decreases the ⁇ aluc and reliability of this method.
  • Another method often used for detecting the female pe riod consists in taking basal temperature.
  • Yet a further object ofthc present invention is to pro ⁇ idc a test for detecting the fertile period or the pres ence of pregnancy which test is contenicnt. safe. reliable and easy to use.
  • Yet another primary object of the present invention is to provide a purely chemical test for ascertaining the period of ovulation. which test does not require animals or complicated calculations. and which test can be simply accomplishcd by mixing chemicals with a female biological medium or contacting the medium with a test strip that develops a color to indicate the period of ovulation.
  • Still a further object of the invention is to provide a method for earliest detection of the pregnant state which detection can be used for achieving better medical care.
  • test is comprised of assaying a biological female medium such as saliva. vaginal fluid. cervical fluid and the like by mixing an aliquot of the female fluid medium with a color forming reagent and then observing or measuring the developed color.
  • a biological female medium such as saliva. vaginal fluid. cervical fluid and the like
  • the medium and the reagent are mixed in the presence of a first buffer. and after a short reaction period of about I hour.
  • a second buffer is added to more fully intensify the color and the absorbance measured in a standard spectrophotometer.
  • a bihulous material is impregnated with a color developing reagent and a buffer and then contacted with a female fluid. After a like short period of time.
  • test material is dipped or sprayed with a different buffer to more fully develop a visible color.
  • This color test material then is compared against a previ ously prepared color chart. In both embodiments. the color indicates the fertile period or the presence of pregnancy. and this knowledge can be used for achieving conception or for rhythmic contraception or for ascertaining the pregnant state.
  • the color developing reagent suitable for the purpose of the present invention is selected from the commercially available compounds p-nitrophenyl-n-acetyll3-d-glucosaminidc. a-naphthofn-acetyl-B-dglucosaminidc.l-[p-nitrocatcchol]-n-acetyl-B d glucosaminide. Z-lp-nitrocatechol]-n-acetyl-B-dglucosaminide. and 3.3-bist p-hydroxyphenyl phthalidn-acctyl-,B-d-glucosaminide.
  • the buffers used for the purpose of the invention are of two kinds. A first buffer system with a pH range of about 4 to 5. and a second buffer system with a pH range of about 9 to II.
  • Materials suitable for compounding the first buffer are sodium citrate and citric acid. and the buffer used is (Li M adjusted to 10.3.
  • the test is conveniently carried out by first mixing a sample of a female fluid. such as. (H ml of saliva with ().l ml of buffered substrate comprised of. for example. ttl M sodium citrate-citric acid buffer with 0.2 ml ft). l M sodium citrate buffer. Then. after shaking until the reagents are mixed. the reagents are permitted to incubate for St) minutes at room tertiperature. to allow the enzyme N-acetyl-,8- glucosamieridase present in the saliva to hydrolytically act on the substrate p-nitrophenyl-n-acetyl-fi-dglucosaminide. At the end of the incubation period.
  • a female fluid such as. (H ml of saliva with ().l ml of buffered substrate comprised of. for example. ttl M sodium citrate-citric acid buffer with 0.2 ml ft). l M sodium citrate buffer.
  • a second buffer consisting of l.t) ml of 1.0 M sodium glycinate buffer is added to the reaction to stop the hydrolytic activity and also to develop the color.
  • the absorbance is measured at 400 nm and compared to a standard curve prepared with solutions of known concentrations of p-nitrophenol.
  • the hibulous materials suitable for the practice of the invention are those materials, which by means of capil lary action or any other physical chemical technique are able to hold liquids.
  • Such materials include test paper that is preferably an absorhant paper. filter pa per. cellulose strips. wood strips. felt. porous ceramic strips. assorted cotton substrates and the like.
  • a typical test paper is prepared for oral use or for contacting cervical or vaginal mucous by impregnating the porous strip with. for example.
  • the test paper so prepared is used to determine the fertility period as evidenced by changes in. for example. the saliva ofthe female.
  • the female simply touches the test paper to her tongue to wet it and then waits about It) to 40 minutes. usually 30 minutes. at room temperature for the increase in N-acetyl- B-d-glucosaminidc to form a color developing compound.
  • the color is more fully developed by wetting the test strip with a small but effective amount of previously prepared (1.1 M sodium glycinate buffer.
  • the test strip is then compared to a standard color card that has a series of color spots similarly developed front known concentrations of the color developing compound pnitrophenol.
  • the test implement will change or develop a maximum color during the period of ovulation and fertility of the female. and it vvill undergo a minimum or no color change at other times. This detection can be used for conception or for rhythmic contraception.
  • the test is used in like fashion for indicating the prev cnce of pregnancy.
  • HG. 2 the activity of alkaline phosphatase in saliva during the menstrual cycle is presented as measured by a standard prior art method to illustrate the improved and unobvious results obtained by the N-acetyl-B-glucosamindase method of the invention as seen in FIG. 1.
  • the standard alkaline phosphatase test is performed by first preparing a sodium or potassium glycinate O.l M buffer adjusted to pH 9.6 and a buffered substrate comprised of 0.01 M pnitrophenylphosphate dissolved in glycine buffer, 0.1 M. pH 9.6. The test is performed by adding It) ml of buffered substrate mixture to (1.2 ml of saliva. with shaking and incubation for 45 minutes at 37C. After this period of time. the color developed is measured at 400 nm. nanometer. and compared to a standard curve.
  • the results in FIG. 2 are presented in a manner identical with the results presented in FIG. 1.
  • FIG. 3 the activity of acid phosphatase in saliva during the menstrual cycle is presented as measured by a standard prior art method. This result is presented to illustrate the unobvious and improved results obtained by the inventive glycosidase method as seen in FIG. 1.
  • the standard test is carried out by first preparing an acetic acid sodium acetate 1.0 M buffer adjusted to pH 4.7. a buffered substrate comprised of p-nitrophenylphosphate disodium salt. 0.] M. dissolved in U.l M sodium acetate buffer adjusted to pH 4.7. and lastly an (1.1 M sodium alkaline glycine buffer adjusted to pH 10.3.
  • the test consists of adding 0.1 ml of the buffered substrate and 0.2 ml of acetate buffer to (H ml of saliva. followed by shaking and incubation for 30 minutes at room temperature. At the end of this period. l.t) ml of glycine buffer is added to the reaction mixture. with the results measure at 400 nm and compared to a standard curve.
  • FIG. 4 is the determination of the peak. second of maximum activity of N-acetyl-B-glucosamindase and its relationship with pregnancy. ln Fl(]. 4. the graft is normalized so that the first day of menstruation occurred or was expected to occur.
  • the vertical lined area of the curved area is the range of 40 female patients with normal menstruation.
  • the horizontal lined area of the curved area is the range of pregnancy of eight patients who used the test for achieving this resuit.
  • the numbers on the left of the Figure represent the optical density. that is. the absorbance or intensity of the color developed for the test.
  • the present invention relates to an improved test. an article and method which are especially useful for determining the female fertile period or the presence of prcnancy.
  • the test comprises a color developing compound and buffers. and the test article is a bibulous material impregnated with same: and. while the invention is described in detail. It is understood that the foregoing detailed description is given for the purpose of illustration and that many variations may be made therein without departing from the spirit of the inventionv What is claimed is:
  • which article is comprised of a bibulous material containing impregnated therein a nontoxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of the color indicator p-nitrophen -l-n-acetyl-B-d-glucosaminide which in the presence of an increase of N-acetyl-B-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
  • a test article useful for detecting an increased N-acet vl-[i-glucosaminadase activit)- according to claim 1 which additionally includes as a color intensifier a separate buffer capable of maintaining the pH in the range of 9 to l l.
  • a test article useful for detecting an increase of N-acetyl-B-glucosaminadase in a female biological media which is coincident with the presence of pregnanc v in a female.
  • which article is comprised of a bibulous absorbent strip-shaped material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of a color indicator selected from the group of indicators consisting essential]; of Pnitrophenyl-nacctvl-[3-d-glueosaminide. a-naphthol-n-acctyl-Balglueosaminide.
  • a diagnostic test for the detection of the fertile period of a female warm-blooded animal which test is comprised of adding a female media selected from the group consisting of saliva. cervical fluid and vaginal fluid to a coltipositiolt consisting of the color indicator p-nitrophent l-n-acetyl-B-d-glucosaminide in an amount sufficient to develop a color in the presence of N-acetvl-li-glucosaniinadase in the media indicating fertility and ovulation and a biologically acceptable first buffer capable of maintaining the pH in the range of 4 to 5 to form a color developing compound. then adding a second buffer capable of maintaining the pH in the range of J to ll to further develope the color which indicates the presence of said fertile period of the female.
  • a method for indicating when to use rhythmic contraception adapted to a female which method is cornrised of determining the fertile period ofthe female by adding a female media selected from the group consist ing of saliva. cervical mucosa and vaginal mucosa to a mixture consisting of the color indicator p-nitrophenyln-acetvl-l3-d-glucosaminide present in an amount suffi' cient to develop a color in the presence of N-acetyl-B- glucosaminadase in the media and a biological acceptable buffcr capable of maintaining the pH in the range of -l to 5 to form a color developing compound.
  • a bu ffcr capable of maintaining the pH in the range of to ll to further develop the color.
  • which color indicates the fertile period that occurs during ovulation of the female which developed color is a means for determining when to use said method of rli vthmic contraception 6.
  • a method for indicating the fertile period of the female that occurs during mulation by detecting an increase in the Lll/ ⁇ lll N-acetvlfi'glucosamindase which is coincident with the fertile period of the female wherein the method is comprised of contacting female saliva containing the increase of N ttCt)'l-B glucosamindase with the color indicator substrate p- 5 nitrophenyl-n-acctyl-l:l-d-glucosaminide which is present in an effective amount to form the color developing compound p-nitrophenyl in the presence ofa buffer capable of maintaining the pH in the range of 4 to 5. then adding another buffer capable of maintaining the pH in the range of 9 to l l to further develop the color which color indicates the fertile period of the female.
  • a method for indicating the presence of pregnancy in a female by detecting an increase in the enzyme N-acetvl-B-glucosaminidase which is coincident with pregnancy wherein the method is comprised of contacting a female fluid excretion with a composition containing the color indicator substrate p-nitrophenyln-acctyl-B-d-glucosaminidc which is contained in the composition in an effective amount to form the color developing compound p-nitrophenyl in the presence of a buffer capable of maintaining the pH in the range of 4 to 5. then adding a buffer capable of maintaining the pH in the range of 9 to l l to further develop the color which color indicates the presence of pregnancy in the female.
  • which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of4 to 5 and an effective amount of the color indicator a-naphthol-n-acet 'l-B-d-glucosaminide which in the presence of an increase of N-acctvl-B- glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
  • a test article useful for detecting an increase of N-acetylB-glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female.
  • which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the 'ange of4 to 5 and an effective amount of the color indicator l-lp-nitrucatecholl-n-acetyl-B-dglucosaminidc which in the presence of an increase of N-acetyl-B-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
  • which article is comprised of a bibulous material containing impregnated therein a nontoxic buffer capable of maintaining the pH in the range of 4 to 5 and the color indicator 3.3- bist p-hvdroxyphenvl )-phthalid-n-acetvl-[3-dglucosaminide in an effective amount which in the presence of an increase of N-acetvl-/3-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.

Abstract

An article of manufacture and a test is provided for detecting the fertile period or the presence of pregnancy in the female. The article is comprised of a porous support impregnated with at least one color developing compound such as p-nitrophenyl-nacetyl- Beta -d-glucosaminide and at least one buffer that develops a color when contacted with a female biological medium. The development of the marked color is coincident with the fertile period, which indication of the fertile period can be used either for achieving fertilization or for preventing conception by the rhythmic method. Also, in the days preceding the expected menstrual period, the development of the marked color is coincident with the presence of pregnancy.

Description

United States Patent 1 Manautou et al.
1 i ARTICLE FOR DETECTING THE FERTILE PERIOD AND METHOD FOR USING SAME 175] Inventors: Jorge Martinez Manautou; Adolfo Rosado Garcia, both of Mexico City, Mexico [73] Assignee: Alza Corporation, Palo Alto. Calif.
[22] Filed: Feb. 16, 1973 12]} App]. No.: 333,029
[52] U.S. Cl. 195/1035 R, 195/99 [51] Int. Cl. G0ln 31/14 {58] Field of Search 195/1035 R, 103.5 C
[561 References Cited UNITED STATES PATENTS 3 h'-)9 (l(l5 10/1972 Foster H 195/1035 [451 Apr. 1, 1975 PITHILH') E.\'mninerAlvin E. Tanenholtz Attorney, Agent, or Firm-Paul L. Sabatine; Edward L. Mandell; William H. Benz 57 ABSTRACT An article of manufacture and a test is provided for detecting the fertile period or the presence of pregnancy in the female. The article is comprised of a porous support impregnated with at least one color developing compound such as p-nitrophenyl-n-acetyLB- d-glucosaminide and at least one buffer that develops a color when contacted with a female biological medium. The development of the marked color is coincident with the fertile period, which indication of the fertile period can be used either for achieving fertilization or for preventing conception by the rhythmic method. Also, in the days preceding the expected menstrual period. the development of the marked color is coincident with the presence of pregnancy.
10 Claims, 4 Drawing Figures PATENTEUAPR 1 5875 SHEET 1 BF 2 l M'zd DAYS BEFORE MENSTRUATION Fl G. 2 PRIOR ART PATENIEBAPR 1 1925 3,875.01 3
sum 2 I 2 FIG.3 mq PRIOR ART 1 I I l I I I l l 1 l I -2'4 -22 -2o -|8 -|6 44 -|2 -m -a -e -4 -2 ++2 +4 DAYS BEFORE MENSTRUATION FIG.4
i 0.2- E o W DAYS BEFORE MENSTRUATION 1 ARTICLE FOR DETECTING THE FERTILE PERIOD AND METHOD FOR USING SAME BACKGROUND OI' THE DISCLOSURE This invention relates to both a novel article useful for detecting the fcrtile period of the female. the pres ence of pregnancy and to a novel test method suitable for detecting the said fertile period or the presence of pregnancy.
In the past. as well as in the present. there has been considerable interest in detecting the fertile period of the female. that is. the time during which the female is capable of reproduction. and also considerable interest in ascertaining the presence of pregnancy. This interest in detecting the fertile period for having an offspring. and also to those who wish to abstain during this period to avoid having an offspring. The interest in detecting the presence of pregnancy is important to those who desire to provide medical care for the health of the female and the offspring and also for interrupting an unwanted pregnancy. However. before this invention. the means and methods used for ascertaining the fertile period or the presence of pregnancy have been fraught with difficulty and uncertainty. For example. one at tempt to ascertain the fertile period or the like was based on the idea that the fertile period is usually a certain number of days before menstruation. That is. the period of fertility. or ovulation in the human female is sct from II to lo days before the next menstrual period and this calculation is used for the intended purpose. However. calculations based on the onset of menscs are often inaccurate because the human female may o\ulatc at varying and unpredictable times. Additionally. the length of life of the ova and the spermatozoa. which information is not truly known in vivo. must also be added to the calculated period which further decreases the \aluc and reliability of this method. Another method often used for detecting the female pe riod consists in taking basal temperature. but this method is not only inconvenient. it additionally re quires considerable skill in observing. recording and interpreting the data. Recently. chemical methods for detecting the fertile period based on an increased monocstcrasc or alkaline phosphatase activity were made available to the art. But. while these methods rep resent an advance in the art. they have the shortcoming of failing to define the fertile period by spreading their results over a prolonged period. or they failed to detect pregnancyv Additionally. other prior art methods had the added shortcoming of lacking a positive ability to effccti\cl ascertain in a seemingly uncquavical man ncr the presence of pregnancy.
SI'MMARY OF THE DISCLOSURE Accordingly. it is an immediate object of the present imcntion to prmitlc an article for detecting the fertile period. or the presence of pregnancy that substantially overcomes the difficulties associated with the prior art.
Yet a further object ofthc present invention is to pro \idc a test for detecting the fertile period or the pres ence of pregnancy which test is contenicnt. safe. reliable and easy to use.
It is another object of the present imention to proidc a simply chemical fertility or pregnancy test which can be carried out by the unskilled layman and which test gi\cs re ults with accuracies generally better than those obtainable with heretobefore known fertility tests.
Yet another primary object of the present invention is to provide a purely chemical test for ascertaining the period of ovulation. which test does not require animals or complicated calculations. and which test can be simply accomplishcd by mixing chemicals with a female biological medium or contacting the medium with a test strip that develops a color to indicate the period of ovulation.
Yet still a further object of the invention is to provide a method for detecting ovulation which detection can be used as a time for achieving conception or as a time for rhythmic contraception. Yet still another object of the invention is to provide a method for the diagnosis of pregnancy as early as H) days after fertilization by the color produced. which method introduces a considerable advance over the art previously described.
Still a further object of the invention is to provide a method for earliest detection of the pregnant state which detection can be used for achieving better medical care.
These and other objects. advantages and features of the present invention will be more apparent from a further reading of the specification and the accompanying claims.
DESCRIPTION OF THE INVENTION Turning now in more detail to the actual and useful test. wherein the test is comprised of assaying a biological female medium such as saliva. vaginal fluid. cervical fluid and the like by mixing an aliquot of the female fluid medium with a color forming reagent and then observing or measuring the developed color. In one procedure. the medium and the reagent are mixed in the presence of a first buffer. and after a short reaction period of about I hour. a second buffer is added to more fully intensify the color and the absorbance measured in a standard spectrophotometer. In another test embodiment. a bihulous material is impregnated with a color developing reagent and a buffer and then contacted with a female fluid. After a like short period of time. the test material is dipped or sprayed with a different buffer to more fully develop a visible color. This color test material then is compared against a previ ously prepared color chart. In both embodiments. the color indicates the fertile period or the presence of pregnancy. and this knowledge can be used for achieving conception or for rhythmic contraception or for ascertaining the pregnant state.
The color developing reagent suitable for the purpose of the present invention is selected from the commercially available compounds p-nitrophenyl-n-acetyll3-d-glucosaminidc. a-naphthofn-acetyl-B-dglucosaminidc.l-[p-nitrocatcchol]-n-acetyl-B d glucosaminide. Z-lp-nitrocatechol]-n-acetyl-B-dglucosaminide. and 3.3-bist p-hydroxyphenyl phthalidn-acctyl-,B-d-glucosaminide. Presently. there is at least one of the above color developing reagents present for the test purpose. although a mixture of these developcrs can be used.
The buffers used for the purpose of the invention are of two kinds. A first buffer system with a pH range of about 4 to 5. and a second buffer system with a pH range of about 9 to II. Materials suitable for compounding the first buffer are sodium citrate and citric acid. and the buffer used is (Li M adjusted to 10.3.
In one embodiment. the test is conveniently carried out by first mixing a sample of a female fluid. such as. (H ml of saliva with ().l ml of buffered substrate comprised of. for example. ttl M sodium citrate-citric acid buffer with 0.2 ml ft). l M sodium citrate buffer. Then. after shaking until the reagents are mixed. the reagents are permitted to incubate for St) minutes at room tertiperature. to allow the enzyme N-acetyl-,8- glucosamiriidase present in the saliva to hydrolytically act on the substrate p-nitrophenyl-n-acetyl-fi-dglucosaminide. At the end of the incubation period. a second buffer consisting of l.t) ml of 1.0 M sodium glycinate buffer is added to the reaction to stop the hydrolytic activity and also to develop the color. The absorbance is measured at 400 nm and compared to a standard curve prepared with solutions of known concentrations of p-nitrophenol.
Turning now to the embodiment wherein a bibulous material is impregnated with reagents. generally the hibulous materials suitable for the practice of the invention are those materials, which by means of capil lary action or any other physical chemical technique are able to hold liquids. Such materials include test paper that is preferably an absorhant paper. filter pa per. cellulose strips. wood strips. felt. porous ceramic strips. assorted cotton substrates and the like. A typical test paper is prepared for oral use or for contacting cervical or vaginal mucous by impregnating the porous strip with. for example. 0.] to 0.5 ml of buffered substrate consisting of 0.] M p-nitrophenyl-n acetyl -B-dglucosaminidc described in U.l M sodium citrate buffer. Then. the porous paper is subjected to drying at room temperature. or up to l0t1C without charing the paper. to evaporate the aqueous solvent and leave ac tive ingredients on the paper.
The test paper so prepared is used to determine the fertility period as evidenced by changes in. for example. the saliva ofthe female. In the oral test. the female simply touches the test paper to her tongue to wet it and then waits about It) to 40 minutes. usually 30 minutes. at room temperature for the increase in N-acetyl- B-d-glucosaminidc to form a color developing compound. The color is more fully developed by wetting the test strip with a small but effective amount of previously prepared (1.1 M sodium glycinate buffer. The test strip is then compared to a standard color card that has a series of color spots similarly developed front known concentrations of the color developing compound pnitrophenol. The test implement will change or develop a maximum color during the period of ovulation and fertility of the female. and it vvill undergo a minimum or no color change at other times. This detection can be used for conception or for rhythmic contraception. The test is used in like fashion for indicating the prev cnce of pregnancy.
The unobvious and improved results obtained vvith the test of this invention are more easily seen in the accompanying Figures. In FIG. 1 thcrc is seen the in creased activity of .\'-acctylfi-glucosamindasc in saliva during the female menstrual cycle. The results have been normalized by ascribing a value of ltltl for the highest enzymatic activity during the menstrual cycle. This value always coincides with the peak basal body temperature registered at ovulation. In FIG. 1. the
arrow through zero tl is the beginning of menstruation.
In HG. 2. the activity of alkaline phosphatase in saliva during the menstrual cycle is presented as measured by a standard prior art method to illustrate the improved and unobvious results obtained by the N-acetyl-B-glucosamindase method of the invention as seen in FIG. 1. The standard alkaline phosphatase test is performed by first preparing a sodium or potassium glycinate O.l M buffer adjusted to pH 9.6 and a buffered substrate comprised of 0.01 M pnitrophenylphosphate dissolved in glycine buffer, 0.1 M. pH 9.6. The test is performed by adding It) ml of buffered substrate mixture to (1.2 ml of saliva. with shaking and incubation for 45 minutes at 37C. After this period of time. the color developed is measured at 400 nm. nanometer. and compared to a standard curve. The results in FIG. 2 are presented in a manner identical with the results presented in FIG. 1.
In FIG. 3. the activity of acid phosphatase in saliva during the menstrual cycle is presented as measured by a standard prior art method. This result is presented to illustrate the unobvious and improved results obtained by the inventive glycosidase method as seen in FIG. 1. The standard test is carried out by first preparing an acetic acid sodium acetate 1.0 M buffer adjusted to pH 4.7. a buffered substrate comprised of p-nitrophenylphosphate disodium salt. 0.] M. dissolved in U.l M sodium acetate buffer adjusted to pH 4.7. and lastly an (1.1 M sodium alkaline glycine buffer adjusted to pH 10.3. The test consists of adding 0.1 ml of the buffered substrate and 0.2 ml of acetate buffer to (H ml of saliva. followed by shaking and incubation for 30 minutes at room temperature. At the end of this period. l.t) ml of glycine buffer is added to the reaction mixture. with the results measure at 400 nm and compared to a standard curve.
FIG. 4 is the determination of the peak. second of maximum activity of N-acetyl-B-glucosamindase and its relationship with pregnancy. ln Fl(]. 4. the graft is normalized so that the first day of menstruation occurred or was expected to occur. The vertical lined area of the curved area is the range of 40 female patients with normal menstruation. The horizontal lined area of the curved area is the range of pregnancy of eight patients who used the test for achieving this resuit. The numbers on the left of the Figure represent the optical density. that is. the absorbance or intensity of the color developed for the test.
In summary. the present invention relates to an improved test. an article and method which are especially useful for determining the female fertile period or the presence of prcnancy. The test comprises a color developing compound and buffers. and the test article is a bibulous material impregnated with same: and. while the invention is described in detail. it is understood that the foregoing detailed description is given for the purpose of illustration and that many variations may be made therein without departing from the spirit of the inventionv What is claimed is:
l. A test article useful for detecting an increase of N-acetyl-B-glucosaminadasc in a female biological media which is coincident with the onset of the fertile period of a female. which article is comprised of a bibulous material containing impregnated therein a nontoxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of the color indicator p-nitrophen -l-n-acetyl-B-d-glucosaminide which in the presence of an increase of N-acetyl-B-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
2. A test article useful for detecting an increased N-acet vl-[i-glucosaminadase activit)- according to claim 1 which additionally includes as a color intensifier a separate buffer capable of maintaining the pH in the range of 9 to l l.
3. A test article useful for detecting an increase of N-acetyl-B-glucosaminadase in a female biological media which is coincident with the presence of pregnanc v in a female. which article is comprised of a bibulous absorbent strip-shaped material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of a color indicator selected from the group of indicators consisting essential]; of Pnitrophenyl-nacctvl-[3-d-glueosaminide. a-naphthol-n-acctyl-Balglueosaminide. l-lp-nitrocatecholl-n-acetyl-B-dglucosaminide and 3.3-bistp-hydroxvphenyl)phthalidn-acctvl-B-dglucosaminide which indicator in the presence of an increase of N-acetyl-/3-glucosamindasc in the female biological media forms a color developing compound wherein the color developed indicates the presence of pregnancy.
4. A diagnostic test for the detection of the fertile period of a female warm-blooded animal which test is comprised of adding a female media selected from the group consisting of saliva. cervical fluid and vaginal fluid to a coltipositiolt consisting of the color indicator p-nitrophent l-n-acetyl-B-d-glucosaminide in an amount sufficient to develop a color in the presence of N-acetvl-li-glucosaniinadase in the media indicating fertility and ovulation and a biologically acceptable first buffer capable of maintaining the pH in the range of 4 to 5 to form a color developing compound. then adding a second buffer capable of maintaining the pH in the range of J to ll to further develope the color which indicates the presence of said fertile period of the female.
5. A method for indicating when to use rhythmic contraception adapted to a female which method is cornrised of determining the fertile period ofthe female by adding a female media selected from the group consist ing of saliva. cervical mucosa and vaginal mucosa to a mixture consisting of the color indicator p-nitrophenyln-acetvl-l3-d-glucosaminide present in an amount suffi' cient to develop a color in the presence of N-acetyl-B- glucosaminadase in the media and a biological acceptable buffcr capable of maintaining the pH in the range of -l to 5 to form a color developing compound. then adding a bu ffcr capable of maintaining the pH in the range of to ll to further develop the color. which color indicates the fertile period that occurs during ovulation of the female which developed color is a means for determining when to use said method of rli vthmic contraception 6. A method for indicating the fertile period of the female that occurs during mulation by detecting an increase in the Lll/ \lll N-acetvlfi'glucosamindase which is coincident with the fertile period of the female wherein the method is comprised of contacting female saliva containing the increase of N ttCt)'l-B glucosamindase with the color indicator substrate p- 5 nitrophenyl-n-acctyl-l:l-d-glucosaminide which is present in an effective amount to form the color developing compound p-nitrophenyl in the presence ofa buffer capable of maintaining the pH in the range of 4 to 5. then adding another buffer capable of maintaining the pH in the range of 9 to l l to further develop the color which color indicates the fertile period of the female.
7. A method for indicating the presence of pregnancy in a female by detecting an increase in the enzyme N-acetvl-B-glucosaminidase which is coincident with pregnancy. wherein the method is comprised of contacting a female fluid excretion with a composition containing the color indicator substrate p-nitrophenyln-acctyl-B-d-glucosaminidc which is contained in the composition in an effective amount to form the color developing compound p-nitrophenyl in the presence of a buffer capable of maintaining the pH in the range of 4 to 5. then adding a buffer capable of maintaining the pH in the range of 9 to l l to further develop the color which color indicates the presence of pregnancy in the female.
8. A test article useful for detecting an increase of N-acetyl-B-glucosaminadasc in a female biologi al media which increase is coincident with the onset of the fertile period of a female. which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of4 to 5 and an effective amount of the color indicator a-naphthol-n-acet 'l-B-d-glucosaminide which in the presence of an increase of N-acctvl-B- glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
9. A test article useful for detecting an increase of N-acetylB-glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female. which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the 'ange of4 to 5 and an effective amount of the color indicator l-lp-nitrucatecholl-n-acetyl-B-dglucosaminidc which in the presence of an increase of N-acetyl-B-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
10. A test article useful for detecting an increase of N-acetyl-B-glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female. which article is comprised of a bibulous material containing impregnated therein a nontoxic buffer capable of maintaining the pH in the range of 4 to 5 and the color indicator 3.3- bist p-hvdroxyphenvl )-phthalid-n-acetvl-[3-dglucosaminide in an effective amount which in the presence of an increase of N-acetvl-/3-glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.

Claims (10)

1. A TEST ARTICLE USEFUL FOR DETECTING AN INCREASE OF N-ACETYLB-GLUCOSAMINADASE IN A FEMALE BIOLOGICAL MEDIA WHICH IS COINCIDENT WITH THE ONSET OF THE FERTILE PERIOD OF A FEMALE, WHICH ARTICLE IS COMPRISED OF A BIBULOUS MATERIAL CONTAINING IMPREGNATED THEREIN A NON-TOXIC BUFFER CAPABLE OF MAINTINING THE PH IN THE RANGE OF 4 TO 5 AND AN EFFECTIVE AMOUNT OF THE COLOR INDICATOR P-NITROPHENYL-N-ACETYL-B-D-GLUCOSAMINIDE WHICH IN THE PRESENCE OF AN INCREASE OF N-ACETYL-BGLUCOSAMINADASE IN THE FEMALE BIOLOGICAL MEDIA FORMS A COLOUR DEVELOPING COMPOUND USEFUL FOR DETECTING THE FERTILE PERIOD.
2. A test article useful for detecting an increased N-acetyl-Beta -glucosaminadase activity according to claim 1 which additionally includes as a color intensifier a separate buffer capable of maintaining the pH in the range of 9 to 11.
3. A test article useful for detecting an increase of N-acetyl-Beta -glucosaminadase in a female biological media which is coincident with the presence of pregnancy in a female, which article is comprised of a bibulous absorbent strip-shaped material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of a color indicator selecteD from the group of indicators consisting essentially of p-nitrophenyl-n-acetyl- Beta -d-glucosaminide, Alpha -naphthol-n-acetyl- Beta -d-glucosaminide, 1-(p-nitrocatechol)-n-acetyl- Beta -d-glucosaminide and 3,3-bis(p-hydroxyphenyl)phthalid-n-acetyl- Beta -d-glucosaminide which indicator in the presence of an increase of N-acetyl- Beta -glucosamindase in the female biological media forms a color developing compound wherein the color developed indicates the presence of pregnancy.
4. A diagnostic test for the detection of the fertile period of a female warm-blooded animal which test is comprised of adding a female media selected from the group consisting of saliva, cervical fluid and vaginal fluid to a composition consisting of the color indicator p-nitrophenyl-n-acetyl- Beta -d-glucosaminide in an amount sufficient to develop a color in the presence of N-acetyl- Beta -glucosaminadase in the media indicating fertility and ovulation and a biologically acceptable first buffer capable of maintaining the pH in the range of 4 to 5 to form a color developing compound, then adding a second buffer capable of maintaining the pH in the range of 9 to 11 to further develope the color which indicates the presence of said fertile period of the female.
5. A method for indicating when to use rhythmic contraception adapted to a female which method is comprised of determining the fertile period of the female by adding a female media selected from the group consisting of saliva, cervical mucosa and vaginal mucosa to a mixture consisting of the color indicator p-nitrophenyl-n-acetyl- Beta -d-glucosaminide present in an amount sufficient to develop a color in the presence of N-acetyl- Beta -glucosaminadase in the media and a biological acceptable buffer capable of maintaining the pH in the range of 4 to 5 to form a color developing compound, then adding a buffer capable of maintaining the pH in the range of 9 to 11 to further develop the color, which color indicates the fertile period that occurs during ovulation of the female which developed color is a means for determining when to use said method of rhythmic contraception.
6. A method for indicating the fertile period of the female that occurs during ovulation by detecting an increase in the enzyme N-acetyl- Beta -glucosamindase which is coincident with the fertile period of the female wherein the method is comprised of contacting female saliva containing the increase of N-acetyl-Beta -glucosamindase with the color indicator substrate p-nitrophenyl-n-acetyl- Beta -d-glucosaminide which is present in an effective amount to form the color developing compound p-nitrophenyl in the presence of a buffer capable of maintaining the pH in the range of 4 to 5, then adding another buffer capable of maintaining the pH in the range of 9 to 11 to further develop the color which color indicates the fertile period of the female.
7. A method for indicating the presence of pregnancy in a female by detecting an increase in the enzyme N-acetyl- Beta -glucosaminidase which is coincident with pregnancy, wherein the method is comprised of contacting a female fluid excretion with a composition containing the color indicator substrate p-nitrophenyl-n-acetyl- Beta -d-glucosaminide which is contained in the composition in an effective amount to form the color developing compound p-nitrophenyl in the presence of a buffer capable of maintaining the pH in the range of 4 to 5, then adding a buffer capable of maintaining the pH in the range of 9 to 11 to further develop the color which color indicates the presence of pregnancy in the female.
8. A test article useful for detecting an increase of N-acetyl-Beta -glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female, which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable Of maintaining the pH in the range of 4 to 5 and an effective amount of the color indicator Alpha -naphthol-n-acetyl- Beta -d-glucosaminide which in the presence of an increase of N-acetyl- Beta -glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
9. A test article useful for detecting an increase of N-acetyl-Beta -glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female, which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of 4 to 5 and an effective amount of the color indicator 1-(p-nitrocatechol)-n-acetyl- Beta -d-glucosaminide which in the presence of an increase of N-acetyl- Beta -glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
10. A test article useful for detecting an increase of N-acetyl-Beta -glucosaminadase in a female biological media which increase is coincident with the onset of the fertile period of a female, which article is comprised of a bibulous material containing impregnated therein a non-toxic buffer capable of maintaining the pH in the range of 4 to 5 and the color indicator 3,3-bis(p-hydroxyphenyl)-phthalid-n-acetyl- Beta -d-glucosaminide in an effective amount which in the presence of an increase of N-acetyl- Beta -glucosaminadase in the female biological media forms a color developing compound useful for detecting the fertile period.
US333029A 1973-02-16 1973-02-16 Article for detecting the fertile period and method for using same Expired - Lifetime US3875013A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US333029A US3875013A (en) 1973-02-16 1973-02-16 Article for detecting the fertile period and method for using same
US05/562,743 US3968011A (en) 1973-02-16 1975-03-27 Test implement and test method for colorimetrically determining whether a female is fertile or pregnant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US333029A US3875013A (en) 1973-02-16 1973-02-16 Article for detecting the fertile period and method for using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US05/562,743 Continuation-In-Part US3968011A (en) 1973-02-16 1975-03-27 Test implement and test method for colorimetrically determining whether a female is fertile or pregnant

Publications (1)

Publication Number Publication Date
US3875013A true US3875013A (en) 1975-04-01

Family

ID=23300953

Family Applications (1)

Application Number Title Priority Date Filing Date
US333029A Expired - Lifetime US3875013A (en) 1973-02-16 1973-02-16 Article for detecting the fertile period and method for using same

Country Status (1)

Country Link
US (1) US3875013A (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968011A (en) * 1973-02-16 1976-07-06 Alza Corporation Test implement and test method for colorimetrically determining whether a female is fertile or pregnant
US4318986A (en) * 1977-11-01 1982-03-09 National Research Development Corporation Enzyme assays
US4670256A (en) * 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
US5011964A (en) * 1985-03-07 1991-04-30 Cornell Research Foundation, Inc. Novel diacylglycerophosphoric acid esters and use thereof as substrates in enzyme assays
EP0433855A2 (en) * 1989-12-21 1991-06-26 Roche Diagnostics GmbH N- and O-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
US5211182A (en) * 1991-10-23 1993-05-18 Deutsch Marshall E Home ovulation test kit and method
US6234974B1 (en) 1992-08-21 2001-05-22 Unilever Patent Holdings B.V. Monitoring method
US6451619B1 (en) 1994-06-29 2002-09-17 Inverness Medical Switzerland Gmbh Monitoring methods and devices for use therein
US6454726B1 (en) 1992-08-21 2002-09-24 Inverness Medical Switzerland Gmbh Monitoring method
US20020137220A1 (en) * 1996-09-27 2002-09-26 Inverness Medical Switzerland Gmbh Monitoring methods
US6585663B1 (en) 1992-08-21 2003-07-01 Inverness Medical Switzerland Gmbh Advisory method
US6951631B1 (en) 1996-09-27 2005-10-04 Inverness Medical Switzerland Gmbh Test kits and devices
US7044919B1 (en) 1998-04-02 2006-05-16 Michael Catt Test methods, devices and test kits
US7141212B2 (en) 1993-11-12 2006-11-28 Inverness Medical Switzerland Gmbh Reading devices and assay devices for use therewith
US20070249958A1 (en) * 2006-04-20 2007-10-25 Kimberly-Clark Worldwide, Inc. Method for detecting the onset of ovulation
US7700305B2 (en) * 1999-09-17 2010-04-20 N2Itive1 Innovations Analyte detection
US20100233723A1 (en) * 2006-01-19 2010-09-16 Lattec I/S Dry stick device and method for determining an analyte in a sample
US20110039290A1 (en) * 2006-01-19 2011-02-17 Kim Clausen Novel dry stick device construction and method for determining an analyte in a sample using said dry stick device
US20120263694A1 (en) * 2009-04-01 2012-10-18 Susan Mary Lennox Intimate Lubrication Kit
CN104297181A (en) * 2014-10-10 2015-01-21 宁波大学 Detection reagent of N-acetyl-beta-D-glucosaminidase
CN106442503A (en) * 2016-09-30 2017-02-22 广州鸿琪光学仪器科技有限公司 Acetylglucosaminidasedetection reagent, reaction pad, preparation method of reaction pad and kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699005A (en) * 1966-11-29 1972-10-17 Raymond O Foster Method and article for detecting the fertile period

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699005A (en) * 1966-11-29 1972-10-17 Raymond O Foster Method and article for detecting the fertile period

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968011A (en) * 1973-02-16 1976-07-06 Alza Corporation Test implement and test method for colorimetrically determining whether a female is fertile or pregnant
US4318986A (en) * 1977-11-01 1982-03-09 National Research Development Corporation Enzyme assays
US5011964A (en) * 1985-03-07 1991-04-30 Cornell Research Foundation, Inc. Novel diacylglycerophosphoric acid esters and use thereof as substrates in enzyme assays
US4670256A (en) * 1985-09-23 1987-06-02 V. Valhalla Corp. Vaginal conditioning for sexual activity
EP0433855A2 (en) * 1989-12-21 1991-06-26 Roche Diagnostics GmbH N- and O-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
EP0433855A3 (en) * 1989-12-21 1995-03-22 Boehringer Mannheim Gmbh N- and o-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
US5525480A (en) * 1989-12-21 1996-06-11 Boehringer Mannheim Gmbh N- and O-substituted aminophenols, method and use for diagnosis
US5211182A (en) * 1991-10-23 1993-05-18 Deutsch Marshall E Home ovulation test kit and method
US6585663B1 (en) 1992-08-21 2003-07-01 Inverness Medical Switzerland Gmbh Advisory method
US6234974B1 (en) 1992-08-21 2001-05-22 Unilever Patent Holdings B.V. Monitoring method
US6454726B1 (en) 1992-08-21 2002-09-24 Inverness Medical Switzerland Gmbh Monitoring method
US7141212B2 (en) 1993-11-12 2006-11-28 Inverness Medical Switzerland Gmbh Reading devices and assay devices for use therewith
US6451619B1 (en) 1994-06-29 2002-09-17 Inverness Medical Switzerland Gmbh Monitoring methods and devices for use therein
US20020137220A1 (en) * 1996-09-27 2002-09-26 Inverness Medical Switzerland Gmbh Monitoring methods
US6951631B1 (en) 1996-09-27 2005-10-04 Inverness Medical Switzerland Gmbh Test kits and devices
US20060083658A1 (en) * 1996-09-27 2006-04-20 Michael Catt Test kits and devices
US7632460B2 (en) 1996-09-27 2009-12-15 Inverness Medical Switzerland Gmbh Test kits and devices
US7044919B1 (en) 1998-04-02 2006-05-16 Michael Catt Test methods, devices and test kits
US8323914B2 (en) 1998-09-18 2012-12-04 N2Itive1 Innovations Analyte detection
US7700305B2 (en) * 1999-09-17 2010-04-20 N2Itive1 Innovations Analyte detection
US20100255497A1 (en) * 1999-09-17 2010-10-07 N2Itive1 Innovations Analyte detection
US8067188B2 (en) 1999-09-17 2011-11-29 N2Itive1 Innovations Analyte detection
US20100233723A1 (en) * 2006-01-19 2010-09-16 Lattec I/S Dry stick device and method for determining an analyte in a sample
US20110039290A1 (en) * 2006-01-19 2011-02-17 Kim Clausen Novel dry stick device construction and method for determining an analyte in a sample using said dry stick device
US8460863B2 (en) 2006-01-19 2013-06-11 Lattec I/S Dry stick device and method for determining an analyte in a sample
US8198073B2 (en) 2006-01-19 2012-06-12 Lattec I/S Dry stick device and method for determining an analyte in a sample
US8206944B2 (en) 2006-01-19 2012-06-26 Lattec I/S Dry stick device construction and method for determining an analyte in a sample using said dry stick device
US20070249958A1 (en) * 2006-04-20 2007-10-25 Kimberly-Clark Worldwide, Inc. Method for detecting the onset of ovulation
US7977103B2 (en) * 2006-04-20 2011-07-12 Kimberly-Clark Worldwide, Inc. Method for detecting the onset of ovulation
US20120263694A1 (en) * 2009-04-01 2012-10-18 Susan Mary Lennox Intimate Lubrication Kit
CN104297181A (en) * 2014-10-10 2015-01-21 宁波大学 Detection reagent of N-acetyl-beta-D-glucosaminidase
CN106442503A (en) * 2016-09-30 2017-02-22 广州鸿琪光学仪器科技有限公司 Acetylglucosaminidasedetection reagent, reaction pad, preparation method of reaction pad and kit

Similar Documents

Publication Publication Date Title
US3875013A (en) Article for detecting the fertile period and method for using same
US3968011A (en) Test implement and test method for colorimetrically determining whether a female is fertile or pregnant
Binder et al. Gingival fluid levels of acid and alkaline phosphatase
Jaques et al. A method for the determination of heparin in blood
US3814668A (en) Method and device for the semi-quantitative determination of glucose in aqueous fluids
US3485587A (en) Protein indicator
US3235337A (en) Diagnostic compositions and test indicators
Chauncey et al. Comparative enzyme activity of saliva from the sheep, hog, dog, rabbit, rat, and human
US3472738A (en) Test implement for detecting peroxidase
SU663329A3 (en) Method of determining isoenzymes of lactatedehydrohenase
US2854317A (en) Method and composition for testing bilirubin in urine
CA1242707A (en) PHENOLSULPHONPHTHALEINYL-.beta.-D-GALACTOSIDES, A PROCESS FOR THE PREPARATION THEREOF AND DIAGNOSTIC AGENTS CONTAINING THEM
US4005984A (en) Diagnostic composition and method of using the same
Gomez et al. Qualitative and quantitative determinations of acid phosphatase activity in vaginal washings
US3699005A (en) Method and article for detecting the fertile period
US6063588A (en) Method of diagnosing periodontal disease
US3427225A (en) Test composition,device and method for detecting urea in aqueous fluids
US2999052A (en) Composition for colorimetric test for serum enzymes
Huber et al. Are vaginal fluid concentrations of prolactin, α‐fetoprotein and human placental lactogen useful for diagnosing ruptured membranes?
US3773626A (en) Reagent composition and process for determining gamma-glutamyltranspeptidase
US3461036A (en) Test composition,device and method for detecting urea in aqueous fluids
Elmfors et al. THE DIAGNOSIS OF RUPTURED FETAL MEMBRANES BY MEASUREMENT OF THE DIAM1NE OXIDASE (DAO) ACTIVITY IN VAGINAL FLUID
Willott L-tartrate inhibitable acid phosphatase in semen and vaginal secretions
Murphy et al. Gas chromatographic measurement of blood and urine glucose and other monosaccharides
EP0176246A2 (en) Method and kit for detecting the presence of gum disease